Our Maria Fareri Children's Hospital is the founding center of the Haplo SCD Consortium stem cell transplant clinical trial for sickle cell disease. The trial's goal: to find a more effective way to treat this life-threatening illness. The groundbreaking therapy involves harvesting cells from a tissue-mismatched family donor, re-engineering them through bone marrow stem cell enrichment, and reducing the immune cell components. Much of this work is being done in our Cellular and Tissue Engineering Laboratory. This therapy is giving hope to many families, like Kemario's. A trial participant, Kemario, 6, is now thriving in first grade and no longer battling sickle cell disease crises. At WMCHealth, our commitment is to pioneer innovative treatments that transform lives and offer hope. The Sickle Cell Disease Program at WMCHealth's Maria Fareri Children’s Hospital serves infants, children, adolescents, and young adults. Visit the link in our bio to learn more. #SickleCellAwarenessMon...